Maitri Enterprises Ltd

Appointment details

• Name and designation: Ms. Rajshree Jain appointed Company Secretary and Compliance Officer (KMP).
• Effective date: August 12, 2026.
• Reason for change: Board-approved appointment of CS & CO.
• Professional profile: ICSI member A80535 with corporate and securities law compliance experience.
• Relationships: Not applicable with directors or promoters.
• Governance role: KMP designation with authority for relevant compliance governance.

Financial results

• Unaudited standalone and consolidated results for quarter ended June 30, 2026 approved with Limited Review Reports.
• Trading window to re-open 48 hours after declaration of results.

Auditors and secretarial appointments

• Internal Auditor appointed: CA Bunty Rajkumar Talreja for FY2026-27.
• Secretarial Auditor resigned: M/s SJV & Associates effective Aug 12, 2026.
• Casual vacancy Secretarial Auditor appointed: M/s Nisarg Sharma & Associates.
• Company Secretary and Compliance Officer appointed: Ms. Rajshree Jain, effective Aug 12, 2026.

Governance and regulatory disclosures

• Trading window details disclosed; Annexure A-D details enclosed under Regulation 30.

Auditor remarks and regulatory notes

• Consolidated results include a qualified conclusion due to insufficient audit evidence on subsidiary trade receivables.
• Impairment of Rs. 62.42 lakhs recognized for the subsidiary's long-outstanding receivables; recoverability under review.
• Subsidiary trade receivables stood at Rs. 241.53 lakhs as of June 30, 2026.

Dematerialisation/rematerialisation status

• RTA processed dematerialisation requests for the reporting period and confirmed outcomes to depositories.
• Securities dematerialised have been listed on the stock exchanges where the earlier issues are listed.
• Physical certificates for dematerialisation were mutilated and cancelled after verification.
• Depository's name was substituted as registered owner within 15 days.

Financial Performance 📊

• Standalone Q3 FY26 revenue was Rs. 65.62 crore, down from Rs. 77.60 crore in Q2 FY26.
• Nine months standalone revenue was Rs. 185.82 crore vs Rs. 227.33 crore previous year.
• Standalone Q3 FY26 profit before tax was Rs. 7.28 lakh, down from Rs. 25.50 lakh in Q2 FY26.
• Standalone Q3 FY26 net profit was Rs. 9.16 lakh, versus a loss of Rs. 36.42 lakh in Q3 FY25.
• Consolidated Q3 FY26 revenue was Rs. 108.22 crore, up from Rs. 85.61 crore in Q2 FY26.
• Consolidated Q3 FY26 net loss was Rs. 41.92 lakh, compared to net profit of Rs. 53.78 lakh in Q2 FY26.

Segment Performance 📊

• Standalone Q3 FY26 segment revenue: Services Rs. 33.25 crore, Pharmaceuticals Rs. 13.31 crore.
• Standalone Q3 FY26 segment profit before tax: Services Rs. 37.07 lakh, Pharmaceuticals Rs. 4.59 lakh.
• Consolidated Q3 FY26 segment revenue: Services Rs. 75.67 crore, Pharmaceuticals Rs. 32.55 crore.

Capital & Exceptional Items 🧱

• Rs. 1.04 crore written off as non-current loans and advances in Q3 FY26 (standalone and consolidated).

Working Capital & Receivables 📦

• Trade receivables Rs. 1.80 crore with Rs. 0.75 crore impairment provision after Rs. 23.31 lakh recoveries in nine months FY26.
• Subsidiary BSA Marketing Private Limited is 100% owned and included in consolidated results.

Auditor & Risks ⚠️

• Auditor qualified opinion due to Rs. 36.97 lakh trade payables over 3 years without confirmation.
• Rs. 39.79 lakh non-moving inventory over one year lacks adequate impairment assessment.
• Consolidated auditor qualified opinion also cites subsidiary’s Rs. 1.38 crore long outstanding receivables.

Other Updates 🗓️📍

• Board approved Q3 and nine months FY26 unaudited standalone and consolidated results on February 12, 2026.
• Four investor complaints received in Q3 FY26; one unresolved as of December 31, 2025.
• Company recognized impact of new Indian Labour Codes effective November 21, 2025, based on legal opinion.

Financial Performance 📊

• Approved unaudited standalone and consolidated financial results for Q3 and nine months ended December 31, 2025.
• Approved limited review report for Q3 and nine months ended December 31, 2025.

🗓️ Meeting Details

• Board meeting scheduled for February 12, 2026, at the registered office in Ahmedabad.

📊 Financial Results

• Approval and recording of unaudited financial results for Q3 and nine months ended December 31, 2025.
• Review of Limited Review Report on the unaudited financial results.